
Colin Hardie
Colin Hardie joined Axxam in November 2024 as President Commercial Operations Europe bringing more than 40 years of industry experience within the Contract Research Organization Operational and Business segment.
Colin started his career within the CRO business in 1984. He has a strong background in Preclinical safety assessment, Clinical Research, Drug Discovery.
During his professional tenure, Colin has held several scientific and leadership/managerial positions within the CRO industry. He has held senior business leadership roles in Europe at Harlan (CH), WIL Research (NL), BioIVT (US), and Sygnature Discovery (UK).
His leadership is characterized by a strong focus on people development and motivation.